Aminoglycosides are extremely active antimicrobial agents, particularl
y against bacteremia caused by aerobic gram-negative bacilli. Emergenc
e of resistance during therapy is a rare event. All the aminoglycoside
s, however, possess the potential for renal and otovestibular toxicity
. Despite careful attention to dosage regimens designed to achieve tar
geted peak and trough levels in serum, the incidence of nephrotoxicity
did not change until the advent of once-daily drug regimens. Because
of their strong antibacterial properties, aminoglycosides remain usefu
l for the treatment of serious infections, but drug monitoring has to
be strict to preserve antibacterial activity while avoiding toxicity a
s much as possible.